» Articles » PMID: 33292080

Cyclic Peptide Engineered from Phytocystatin Inhibitory Hairpin Loop As an Effective Modulator of Falcipains and Potent Antimalarial

Overview
Date 2020 Dec 9
PMID 33292080
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Cystatins are classical competitive inhibitors of C1 family cysteine proteases (papain family). Phytocystatin superfamily shares high sequence homology and typical tertiary structure with conserved glutamine-valine-glycine (Q-X-V-X-G) loop blocking the active site of C1 proteases. Here, we develop a cysteine-bounded cyclic peptide (CYS-cIHL) and linear peptide (CYS-IHL), using the conserved inhibitory hairpin loop amino acid sequence. Using an in silico approach based on modeling, protein-peptide docking, molecular dynamics simulations and calculation of free energy of binding, we designed and validated inhibitory peptides against falcipain-2 (FP-2) and -3 (FP-3), cysteine proteases from the malarial parasite . Falcipains are critical hemoglobinases of that are validated targets for the development of antimalarial therapies. CYS-cIHL was able to bind with micromolar affinity to FP-2 and modulate its binding with its substrate, hemoglobin in and assays. CYS-cIHL could effectively block parasite growth and displayed antimalarial activity in culture assays with no cytotoxicity towards human cells. These results indicated that cyclization can substantially increase the peptide affinity to the target. Furthermore, this can be applied as an effective strategy for engineering peptide inhibitory potency against proteases.

Citing Articles

Cystatin from Austrelaps superbus snake venom as a model for identifying potential inhibitors of Trypanosoma cruzi cruzain.

Diaz J, Garay A, Kayano A, Holanda R, Francisco A, Kuehn C J Venom Anim Toxins Incl Trop Dis. 2025; 31:e20240055.

PMID: 39963262 PMC: 11832194. DOI: 10.1590/1678-9199-JVATITD-2024-0055.


Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches.

Nath M, Bhowmik D, Saha S, Nandi R, Kumar D Sci Rep. 2024; 14(1):3246.

PMID: 38332162 PMC: 10853515. DOI: 10.1038/s41598-024-53316-5.


Bioactive Peptides against Human Apicomplexan Parasites.

Rivera-Fernandez N, Anacleto-Santos J, Casarrubias-Tabarez B, Lopez-Perez T, Rojas-Lemus M, Lopez-Valdez N Antibiotics (Basel). 2022; 11(11).

PMID: 36421302 PMC: 9686768. DOI: 10.3390/antibiotics11111658.


iAMAP-SCM: A Novel Computational Tool for Large-Scale Identification of Antimalarial Peptides Using Estimated Propensity Scores of Dipeptides.

Charoenkwan P, Schaduangrat N, Lio P, Moni M, Chumnanpuen P, Shoombuatong W ACS Omega. 2022; 7(45):41082-41095.

PMID: 36406571 PMC: 9670693. DOI: 10.1021/acsomega.2c04465.


A novel cysteine protease inhibitor in Baylisascaris schroederi migratory larvae regulates inflammasome activation through the TLR4-ROS-NLRP3 pathway.

Xu J, Gu X, Xie Y, He R, Xu J, Xiong L Parasit Vectors. 2022; 15(1):334.

PMID: 36151570 PMC: 9508711. DOI: 10.1186/s13071-022-05466-6.